|
市場調査レポート
繊維筋痛市場の予測
Fibromyalgia Market Forecast
|
Abstract
Introduction
Until regulatory hurdles in the EU are overcome, the US offers the greatest
commercial potential and will be the primary growth market for all current and
future brands indicated for fibromyalgia. Datamonitor forecasts the
fibromyalgia market to more than double in value from 2008 to total $2.5
billion by 2018 across the seven major regions.
Key reasons to purchase this research
- Quantify the current and future size of the fibromyalgia market
- Assess the impact of recent and anticipated events (patent expiries, new
product launches, regulatory approval) on the fibromyalgia market
- Understand the country-specific impact of key events in the fibromyalgia
market during the forecast period 2009 to 2018
Table of Contents
OVERVIEW
- This product contains forecasts for fibromyalgia drugs across the seven
major markets from 2009 to 2018. It has been designed for delivery in an excel
data pack format, but for more detail about this disease area please see the
accompanying Forecast Insight: Fibromyalgia word document (DMHC2512).
- The associated report can be found under Latest research in the
Knowledge centre, through the search function or by contacting your sales
representative.
- Please select the data pack option from the download menu at the side of
the page to access the model.
- Introduction
- Scope of this research
- Research and analysis highlights
- Key reasons to read this report
- Forecasting Methodology
- The forecasting model:
- General event information:
- Event selection and quantification:
- Event parameters:
|
